Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-02-23 @ 12:08 PM
Study NCT ID:
NCT02560532
Status:
COMPLETED
Last Update Posted:
2018-07-10
First Post:
2015-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage
Sponsor:
Idorsia Pharmaceuticals Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-01
Start Date Type:
None
Primary Completion Date:
2017-05-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-23
First Submit QC Date:
None
Study First Post Date:
2015-09-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-06
Last Update Post Date:
2018-07-10
Last Update Post Date Type:
ACTUAL